ArticleJournal of pharmaceutics & pharmacology2022

Aticaprant (Clinically Developed Kappa-Opioid Receptor Antagonist) Combined With Naltrexone Prevents Alcohol "Relapse" Drinking.

Y Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.